ACAD Financial Facts

Net loss: -71.61M
Collaborative revenues: 5.27M
See Full Income Statement

See Full Balance Sheet

ACADIA Pharmaceuticals (ACAD) Earnings

  |   Expand Research on ACAD
Next EPS Date 8/4/22 *Est. EPS Growth Rate -66.7% *Last Qtr.
Average EPS % Beat Rate +12.3% Revenue Growth Rate +8.3% *Last Qtr.
Average % Move 1-Wk after EPS -9.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/4/22 Q122 -$0.70-$0.60 -$0.10$115.5M$121.92M = Details
2/28/22 Q421 -$0.27-$0.24 -$0.03$130.76M$135.6M = Details
11/8/21 Q321 -$0.09-$0.26 +$0.17$131.6M$127.75M N/A Details
8/4/21 Q221 -$0.27-$0.31 +$0.04$115.2M$126.15M = Details
5/5/21 Q121 -$0.42-$0.53 +$0.11$106.6M$111.63M N/A Details
2/24/21 Q420 -$0.42-$0.47 +$0.05$121.01M$123.2M N/A Details
11/4/20 Q320 -$0.54-$0.38 -$0.16$120.6M$118.82M = Details
8/5/20 Q220 -$0.27-$0.44 +$0.17$110M$103.34M = Details